Investor profile
British Patient Capital has backed 19 European tech companies across 23 funding rounds between 2021 and 2025, joining rounds totalling €1.7B. Most active in Healthtech and Software. Data as of 6 Aug 2026.
Also recorded as: British PatientCapital
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Quantexa | UK | 3 | €412M |
| Pragmatic | UK | 2 | €245M |
| Thought Machine | UK | 1 | €177M |
| Quell Therapeutics | UK | 1 | €138M |
| Grey Wolf Therapeutics | UK |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Pragmatic | Series D+ | €213M | 2023-12 |
| Thought Machine | Series C | €177M | 2021-11 |
| Quantexa | Series D+ | €164M | 2025-03 |
| Quell Therapeutics |
| 2 |
| €87M |
| Proximie | UK | 1 | €77M |
| Maxion Therapeutics | UK | 1 | €66M |
| Microbiotica | UK | 1 | €61M |
| Form3 | UK | 1 | €54M |
| Quantum Motion | UK | 1 | €48M |
| Oxford Quantum Circuits | UK | 1 | €45M |
| Phagenesis | UK | 1 | €39M |
| Nucleome Therapeutics | UK | 1 | €38M |
| Epsilogen | UK | 1 | €37M |
| Iceotope | UK | 1 | €35M |
| Accurx | UK | 1 | €32M |
| GaN Devices | UK | 1 | €30M |
| Stream (formerly Wagestream) | UK | 1 | €20M |
| CyberSmart | UK | 1 | €14M |
| Series B |
| €138M |
| 2021-11 |
| Quantexa | Series D+ | €130M | 2021-07 |
| Quantexa | Series D+ | €118M | 2023-04 |
| Proximie | Series C | €77M | 2022-06 |
| Maxion Therapeutics | Series A | €66M | 2025-03 |
| Microbiotica | Series B | €61M | 2022-03 |
| Form3 | Series C | €54M | 2024-09 |
